Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Health-related Quality of Life and Patient-reported Outcomes in Pulmonary Arterial Hypertension2008 · 122 citations
2. 2Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study)2012 · 376 citations
3. 3Transitioning from Parenteral Treprostinil to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension2013 · 15 citations
4. 4Validation of the 6-Minute Walk in Patients With Pulmonary Arterial Hypertension2012 · 22 citations
5. 5Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis2014 · 133 citations